January 31, 2018 / 6:27 AM / 23 days ago

Lonza's FY core profit soars 82 pct on acquisitions

ZURICH, Jan 31 (Reuters) - Swiss drug ingredients maker Lonza reported on Wednesday a higher-than-expected 81 percent surge in its core 2017 profit, as the Basel-based company benefited from a slate of acquisitions.

Core profit came in at 806 million Swiss francs ($864.53 million), higher than the 674 million franc average forecast of analysts in a Reuters poll. Company’s sales rose 23.5 percent to 5.1 billion francs, matching the 5.1 billion franc forecast in the poll. (Reporting by John Miller; Editing by Sherry Jacob-Phillips)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below